Three key notes:
1. The new technology is designed for sacroiliac joint fusions that require long construct procedures. The technology can provide greater joint stabilization.
2. SI-Bone previously received clearance for the iFuse minimally invasive sacroiliac joint procedures with the dorsal implantation approach. The broadened indication allows surgeons to place iFuse Bedrock across the sacroiliac joint during long fusions.
3. More than 68 peer-reviewed publications provide clinical evidence supporting the legacy SI-Bone technology, including six-year data.
More articles on spine devices:
Medacta turns 20, focuses on personalized medicine
Smith & Nephew plans expanded robotics R&D location in Pittsburgh: 4 things to know
What device company CEOs were paid in 2018
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
